Allergan has until tomorrow, Friday October 13, to address the question of whether its patent licensing deal with a Native American tribe was a sham.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Allergan, Mylan, patent, IPR, sovereign immunity, Saint Regis Mohawk Tribe, US District Court for the Eastern District of Texas, Claire McCaskill